Le Lézard
Classified in: Health, Science and technology
Subject: PDT

Fluent BioSciences Debuts PIPseqtm V with Unique Molecular Counting Strategy


Novel TruIDtm method Increases transcript yield and overall assay sensitivity.

CAMBRIDGE, Mass., May 29, 2024 /PRNewswire/ -- Fluent BioSciences, a leader in single-cell technology innovation, is proud to herald the launch of our latest product line, the PIPseq V 3' Single Cell RNA Sequencing Kits. This new release marks a significant advancement in molecular quantification, demonstrating our commitment to driving transformative progress in single-cell biology.

Designed to apply to a broad range of research needs, an assortment of PIPseq V kits address a wide scope of sample types and input levels. This scalability makes our product line an affordable option for both small and large-scale projects. The PIPseq V 3' kits bring numerous enhancements over previous versions, delivering notable improvements in both performance and workflow simplicity:

Our cutting-edge TruID technology leverages the random fragmentation of RNA to generate intrinsic identifiers, dramatically enhancing precision and sensitivity. This novel approach reframes the way single-cell experiments are performed and analyzed.

"As Fluent BioSciences continues to lead the charge in innovation within our field, we are delighted to offer a glimpse into an upcoming advancement in single-cell technology," said Brian McKernan, CEO of Fluent BioSciences. "Our forthcoming PIPseq release includes a significant innovation in molecular counting methodologies, promising unparalleled gains in precision and sensitivity increasing yield of transcripts and genes without raising the background giving better visibility to low abundance cell types. This breakthrough opens doors to a myriad of possibilities for enhanced research and analysis capabilities."

The PIPseq V 3' Single Cell RNA Sequencing Kits are poised to set a new standard in the industry, empowering researchers with tools that enable more detailed and precise single-cell studies.  Contact our team at [email protected] for more information or to purchase the PIPseq V kits.

SOURCE Fluent BioSciences


These press releases may also interest you

at 00:00
XSOOH has always been at the forefront of hair care innovation, striving to deliver cutting-edge  products  that enhance the way customers achieve their desired looks. In a world where time is precious, XSOOH  proudly announces the launch of the...

3 jui 2024
In a landmark event signaling its ambitious foray into the biopharmaceutical sector, LOTTE BIOLOGICS, under the leadership of CEO Richard W. Lee, held a groundbreaking ceremony for its inaugural plant at the Songdo Bio Campus in Incheon International...

3 jui 2024
On June 29, the "Gather Great Wisdom to Shape the Future of Intelligent Manufacturing?Special Exhibition on Design Intelligence and High Quality Development", hosted by the China Academy of Art (CAA), opened at the National Museum of China in...

3 jui 2024
Intermap Technologies ("Intermap" or the "Company"), a global leader in 3D geospatial products and intelligence solutions, announces a new financing. The Company is offering up to a maximum of 4,300,000 Class "A" common shares of the Company...

3 jui 2024
"The Classic Quotes by Xi Jinping," a multilingual TV show produced by China Media Group, aired in Kazakhstan on Tuesday after Chinese...

3 jui 2024
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for hematological malignancies, announced today that on July 2, 2024, in relation to...



News published on and distributed by: